Seven pharmaceutical companies and the Innovative Medicines Initiative have launched a €196 million project in a bid to boost academic and industry lead discovery.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Computational systems biology approaches for Parkinson’s disease
Cell and Tissue Research Open Access 29 November 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Mullard, A. European Lead Factory opens for business. Nat Rev Drug Discov 12, 173–175 (2013). https://doi.org/10.1038/nrd3956
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3956
This article is cited by
-
Impact of a five-dimensional framework on R&D productivity at AstraZeneca
Nature Reviews Drug Discovery (2018)
-
Computational systems biology approaches for Parkinson’s disease
Cell and Tissue Research (2018)
-
Malaria medicines: a glass half full?
Nature Reviews Drug Discovery (2015)
-
Opening the lead generation toolbox
Nature Reviews Drug Discovery (2014)